Work

A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection

Year: 1999

Type: article

Study design: Clinical Trial

Source: Antiviral Research

DOI: 10.1016/s0166-3542(98)00058-8

Authors: Rachel W. Humphrey, Kathleen M. Wyvill, Bach-Yen Nguyen, Laura E. Shay, David R. Kohler, Seth M. Steinberg, Takamasa Ueno, Tominaga Fukasawa, Makoto Shintani, Hideya Hayashi, Hiroaki Mitsuya, Robert Yarchoan

Institutions: National Institutes of Health, National Cancer Institute

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2009978613

FWCI: 1.454

Cites: 34

Cited by: 11

Related to: 10